(ENR) Energizer Holdings - Overview
Stock: Batteries, Specialty Batteries, Lighting, Automotive Care, Automotive Chemicals
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.06% |
| Yield on Cost 5y | 3.71% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 97.5% |
| Payout Ratio | 38.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.0% |
| Relative Tail Risk | -13.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.38 |
| Alpha | -36.21 |
| Character TTM | |
|---|---|
| Beta | 0.713 |
| Beta Downside | 0.564 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.59% |
| CAGR/Max DD | -0.17 |
Description: ENR Energizer Holdings January 13, 2026
Energizer Holdings Inc. (NYSE: ENR) manufactures, markets, and distributes a broad portfolio of household and specialty batteries, lighting products, and consumer-care chemicals through brands such as Energizer, Eveready, Rayovac, Varta, Armor All, and STP.
The company’s product mix spans primary and rechargeable batteries, hearing-aid power sources, flashlights (Hard Case, Dolphin, WeatherReady), and automotive-care chemicals, sold via a hybrid channel network that includes direct sales, distributors, mass-merchandisers, e-commerce platforms, and military stores.
Key performance indicators from FY 2023 show revenue of roughly $3.3 billion, an operating margin of 13 %, and a 6 % year-over-year increase in rechargeable-battery sales-reflecting the broader consumer shift toward sustainable power solutions. The battery segment’s outlook is further tied to raw-material cost trends (zinc, lithium) and macro-economic factors such as consumer discretionary spending and global supply-chain resilience.
For a deeper quantitative view, explore ValueRay’s ENR dashboard to see the latest analyst estimates and valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 213.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.97 > 1.0 |
| NWC/Revenue: 25.95% < 20% (prev 21.46%; Δ 4.49% < -1%) |
| CFO/TA 0.05 > 3% & CFO 219.6m > Net Income 213.3m |
| Net Debt (3.29b) to EBITDA (547.5m): 6.02 < 3 |
| Current Ratio: 1.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (68.4m) vs 12m ago -6.56% < -2% |
| Gross Margin: 40.10% > 18% (prev 0.38%; Δ 3972 % > 0.5%) |
| Asset Turnover: 69.17% > 50% (prev 68.60%; Δ 0.57% > 0%) |
| Interest Coverage Ratio: 2.69 > 6 (EBITDA TTM 547.5m / Interest Expense TTM 156.4m) |
Altman Z'' 1.80
| A: 0.18 (Total Current Assets 1.56b - Total Current Liabilities 783.9m) / Total Assets 4.44b |
| B: 0.01 (Retained Earnings 59.2m / Total Assets 4.44b) |
| C: 0.10 (EBIT TTM 421.0m / Avg Total Assets 4.34b) |
| D: -0.04 (Book Value of Equity -165.6m / Total Liabilities 4.30b) |
| Altman-Z'' Score: 1.80 = BBB |
Beneish M -3.17
| DSRI: 0.88 (Receivables 372.8m/410.7m, Revenue 3.00b/2.90b) |
| GMI: 0.95 (GM 40.10% / 38.23%) |
| AQI: 0.96 (AQ_t 0.53 / AQ_t-1 0.56) |
| SGI: 1.03 (Revenue 3.00b / 2.90b) |
| TATA: -0.00 (NI 213.3m - CFO 219.6m) / TA 4.44b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of ENR shares?
Over the past week, the price has changed by +7.19%, over one month by +15.90%, over three months by +0.79% and over the past year by -23.48%.
Is ENR a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ENR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.7 | -3.1% |
| Analysts Target Price | 22.7 | -3.1% |
| ValueRay Target Price | 23.3 | -0.6% |
ENR Fundamental Data Overview February 07, 2026
P/E Forward = 6.6578
P/S = 0.5425
P/B = 9.436
P/EG = 1.5
Revenue TTM = 3.00b USD
EBIT TTM = 421.0m USD
EBITDA TTM = 547.5m USD
Long Term Debt = 3.41b USD (from longTermDebt, last fiscal year)
Short Term Debt = 24.8m USD (from shortTermDebt, last quarter)
Debt = 3.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.29b USD (from netDebt column, last quarter)
Enterprise Value = 4.90b USD (1.60b + Debt 3.51b - CCE 214.8m)
Interest Coverage Ratio = 2.69 (Ebit TTM 421.0m / Interest Expense TTM 156.4m)
EV/FCF = 33.76x (Enterprise Value 4.90b / FCF TTM 145.0m)
FCF Yield = 2.96% (FCF TTM 145.0m / Enterprise Value 4.90b)
FCF Margin = 4.83% (FCF TTM 145.0m / Revenue TTM 3.00b)
Net Margin = 7.11% (Net Income TTM 213.3m / Revenue TTM 3.00b)
Gross Margin = 40.10% ((Revenue TTM 3.00b - Cost of Revenue TTM 1.80b) / Revenue TTM)
Gross Margin QoQ = 32.94% (prev 37.26%)
Tobins Q-Ratio = 1.10 (Enterprise Value 4.90b / Total Assets 4.44b)
Interest Expense / Debt = 1.11% (Interest Expense 39.1m / Debt 3.51b)
Taxrate = 15.87% (45.1m / 284.1m)
NOPAT = 354.2m (EBIT 421.0m * (1 - 15.87%))
Current Ratio = 1.99 (Total Current Assets 1.56b / Total Current Liabilities 783.9m)
Debt / Equity = 24.83 (Debt 3.51b / totalStockholderEquity, last quarter 141.3m)
Debt / EBITDA = 6.02 (Net Debt 3.29b / EBITDA 547.5m)
Debt / FCF = 22.71 (Net Debt 3.29b / FCF TTM 145.0m)
Total Stockholder Equity = 157.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.92% (Net Income 213.3m / Total Assets 4.44b)
RoE = 135.8% (Net Income TTM 213.3m / Total Stockholder Equity 157.1m)
RoCE = 11.81% (EBIT 421.0m / Capital Employed (Equity 157.1m + L.T.Debt 3.41b))
RoIC = 10.18% (NOPAT 354.2m / Invested Capital 3.48b)
WACC = 3.32% (E(1.60b)/V(5.11b) * Re(8.54%) + D(3.51b)/V(5.11b) * Rd(1.11%) * (1-Tc(0.16)))
Discount Rate = 8.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.94%
[DCF Debug] Terminal Value 81.30% ; FCFF base≈175.6m ; Y1≈118.7m ; Y5≈57.4m
Fair Price DCF = N/A (negative equity: EV 1.82b - Net Debt 3.29b = -1.48b; debt exceeds intrinsic value)
EPS Correlation: 7.78 | EPS CAGR: -10.50% | SUE: 0.27 | # QB: 0
Revenue Correlation: 19.88 | Revenue CAGR: 3.47% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.78 | Chg30d=+0.007 | Revisions Net=+0 | Analysts=5
EPS current Year (2026-09-30): EPS=3.42 | Chg30d=-0.010 | Revisions Net=-1 | Growth EPS=-2.9% | Growth Revenue=+2.1%
EPS next Year (2027-09-30): EPS=3.81 | Chg30d=+0.011 | Revisions Net=-1 | Growth EPS=+11.3% | Growth Revenue=+1.1%